Senior insider sale
Chief Legal Officer at AMICUS THERAPEUTICS, INC. — senior position signals high conviction
$955.4K
95.62K shares
What this filing means
ROSENBERG ELLEN plans to sell 95.62K shares of AMICUS THERAPEUTICS, INC. valued at approximately $955.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/26/2025ACC: 0001950047-25-009429
Officer· Chief Legal Officer
Since Jan 2019
95.62K
Shares to sell
$955.4K
Approx. market value
23.62K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
11/26/2025
23.62KTotal acquired23.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/26/2025 | Exercise of Stock Options Cash | 23.62K | — |
| Total | 23.62K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
36K
Market value
$360.0K
11/25/2025
—Completed
Units to sell
36K
Market value
$362.3K
11/24/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
23.62K
Market value
$233.1K
11/26/2025
Total
Units
95.62K
Value
$955.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/25/2025 | 36K | $360.0K | — | Completed |
11/24/2025 | 36K | $362.3K | — | Completed |
| Planned — Approximate Date | ||||
11/26/2025 | 23.62K | $233.1K | NASDAQ | Planned |
| Total | 95.62K | $955.4K | ||